Navigation Links
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned
Date:10/21/2009

STAMFORD, Conn., Oct. 21 /PRNewswire/ -- Zargis Medical Corp., a subsidiary of Speedus Corp. (Nasdaq: SPDE) and a spin-off from Siemens Corporate Research (NYSE: SI), today announced that is has been cleared as an Apple(®) iPhone(®) developer and has begun development of medical diagnostic support software and related peripherals for the iPhone and other leading smartphones.

Zargis has identified the handheld environment as a logical delivery platform for its telemedicine and diagnostic software initiatives, and with its team of experienced developer's plans to leverage the smartphone platform as a mobile hub between medical device peripherals and computer-aided diagnostic support located either locally or remotely.

A recent report released by Manhattan Research stated that 64% of doctors, more than double the number eight years ago, own smartphones, and that this figure will increase to 81% penetration in 2012. However, despite the rapid adoption of the iPhone and other smartphones by physicians, currently available healthcare applications for these devices are generally limited to medical reference libraries, educational tools and applications designed to manage patient medical records.

"The future of healthcare delivery is about connectivity and mobility. Zargis' expertise in computer-aided auscultation and our advanced medical software platform positions us perfectly to create diagnostic software and peripherals that are a natural fit for smartphones. We intend to improve healthcare efficiency by helping clinicians bring medical technology to the patient, rather than the other way around," stated Zargis CEO John Kallassy.

About Zargis Medical Corp.

Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE: SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or phodge@zargis.com or visit the following Web sites: www.zargis.com and www.speedus.com.

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

iPhone and Apple are registered trademarks of Apple Inc.

SOURCE Zargis Medical Corp.


'/>"/>
SOURCE Zargis Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army
2. Zargis Cardioscan(TM) Unveiled Through Global Marketing and Distribution Alliance With 3M Company
3. 3M and Zargis Announce Global Marketing Alliance
4. NBTY Acquisition of Julian Graves Unconditionally Cleared
5. Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test
6. HemAway(R) Launches FDA-Cleared Painless Hemorrhoid Treatment Device
7. Mount Sinai first in US to implant FDA-cleared ring for mitral valve repair
8. Amedica Receives CE Mark for the Worlds First FDA-Cleared Valeo(TM) Ceramic Spinal Implant System
9. Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA
10. OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA
11. Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... KING OF PRUSSIA, PA (PRWEB) , ... December 07, 2016 , ... ... of clinical trials with the announcement that it is one of the early adopters ... EU-U.S. Privacy Shield Framework is designed to provide companies on both sides of the ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA and mental health ... health systems reform legislation in more than fifty years. We applaud the bipartisan ... our elected officials to improving mental health services and supports in our nation. ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... in their bodies, a researcher at the Icahn School of Medicine at Mount ... The study found that when young children are exposed to secondhand marijuana smoke, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Wavelink, an industry leader that ... a new partnership with Splashtop Inc. This remote control for Android extends Wavelink’s ... businesses maximize their uptime and productivity. , Wavelink offers powerful enterprise mobility management ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... acquired Presence Technology, S.L. (“Presence”) for a purchase price of approximately $17.4 ... other considerations. Presence’s annual revenue is approximately $13.2 million. Headquartered in Barcelona, ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
(Date:12/8/2016)... Information products and services provider Elsevier has launched ... world,s largest abstract and citation database of peer-reviewed literature, providing the ... 5,000 publishers. The new set of metrics will improve decisions on ... adjust a journal,s editorial strategy. ... , CiteScore metrics comprise ...
(Date:12/8/2016)... December 8, 2016 According to the ... Pens Market is expected to be worth US$9.7 bn ... in 2015. Between the forecast years of 2016 and 2024, ... of 7.9%. The leading players operating in the global diabetes ... Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A. Transparency Market ...
Breaking Medicine Technology: